📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. (2022)

First Author: HPS3/TIMI55-REVEAL Collaborative Group

Attributed to: Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/eurheartj/ehab863

PubMed Identifier: 34910136

Publication URI: http://europepmc.org/abstract/MED/34910136

Type: Journal Article/Review

Volume: 43

Parent Publication: European heart journal

Issue: 14

ISSN: 0195-668X